Induction Healthcare Group PLC Total Voting Rights (5826J)
April 29 2022 - 2:00AM
UK Regulatory
TIDMINHC
RNS Number : 5826J
Induction Healthcare Group PLC
29 April 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Total Voting Rights
Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that f or
the purpose of the FCA's Disclosure and Transparency Rules, the
Company's issued share capital consists of 92,298,816 Ordinary
Shares of ordinary shares of 0.2p each, with voting rights
("Ordinary Shares"). The Company does not hold any Ordinary Shares
in Treasury. Therefore, the total number of Ordinary Shares in the
Company with voting rights is 92,298,816.
The Company's issued share capital consists of 92,298,816
Ordinary Shares and this number should be used by shareholders in
the Company as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the share capital of the Company
under the FCA's Disclosure and Transparency Rules.
- ENDS-
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated Adviser
and Broker) +44 (0) 20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd +44 (0)20 7933 8780
Alice Woodings / Stephanie Cuthbert
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions through a single integrated platform that transform care
delivery. Our system-wide applications help healthcare providers
and administrators to deliver care at any stage remotely as well as
face-to-face - giving the communities they serve greater
flexibility, control and ease of access . Purpose-built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVREALLXASLAEFA
(END) Dow Jones Newswires
April 29, 2022 02:00 ET (06:00 GMT)
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Induction Healthcare (LSE:INHC)
Historical Stock Chart
From Jul 2023 to Jul 2024